Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 50,582.0 | 29,899.0 | 17,095.0 | 47,007.0 | 44,438.0 | 41,138.0 | 39,450.0 | 40,704.0 |
| Revenue growth | 69.2% | 74.9% | -63.6% | 5.8% | 8.0% | 4.3% | -3.1% | 0.8% |
| Cost of goods sold | 14,591.0 | 21,703.0 | 17,366.0 | 27,940.0 | 28,010.0 | 26,455.0 | 24,602.0 | 26,057.0 |
| Gross profit | 35,991.0 | 8,196.0 | -271.0 | 19,067.0 | 16,428.0 | 14,683.0 | 14,848.0 | 14,647.0 |
| Gross margin | 71.2% | 27.4% | -1.6% | 40.6% | 37.0% | 35.7% | 37.6% | 36.0% |
| Selling, general and administrative | 1,983.0 | | | | | | 2,866.0 | 3,162.0 |
| Sales and marketing | | 953.0 | 643.0 | 2,211.0 | 1,941.0 | 1,827.0 | 1,751.0 | 1,672.0 |
| General and administrative | | 108.0 | | 1,643.0 | 1,301.0 | 1,065.0 | | |
| EBITA | 3,537.0 | 1,877.0 | -4,240.0 | 6,629.0 | 5,281.0 | 5,983.0 | 7,013.0 | 7,820.0 |
| EBITA margin | 7.0% | 6.3% | -24.8% | 14.1% | 11.9% | 14.5% | 17.8% | 19.2% |
| Amortization of intangibles | | 10.0 | 10.0 | 11.0 | 17.0 | 17.0 | 17.0 | 18.0 |
| EBIT | 3,537.0 | 1,867.0 | -4,250.0 | 6,618.0 | 5,264.0 | 5,966.0 | 6,996.0 | 7,802.0 |
| EBIT margin | 7.0% | 6.2% | -24.9% | 14.1% | 11.8% | 14.5% | 17.7% | 19.2% |
| Pre-tax income | 1,914.0 | 398.0 | -15,587.0 | 6,198.0 | 5,151.0 | 5,500.0 | 6,353.0 | 7,157.0 |
| Income taxes | 596.0 | 118.0 | -3,202.0 | 1,431.0 | 1,216.0 | 2,295.0 | 2,158.0 | 2,631.0 |
| Tax rate | 31.1% | 29.6% | 20.5% | 23.1% | 23.6% | 41.7% | 34.0% | 36.8% |
| Net income | 1,318.0 | 280.0 | -12,385.0 | 4,767.0 | 3,935.0 | 3,205.0 | 4,195.0 | 4,526.0 |
| Net margin | 2.6% | 0.9% | -72.4% | 10.1% | 8.9% | 7.8% | 10.6% | 11.1% |
| |
| Diluted EPS | $2.06 | $0.44 | ($19.47) | $7.30 | $5.67 | $4.43 | $5.56 | $5.63 |
| Shares outstanding (diluted) | 641.0 | 641.0 | 636.0 | 653.0 | 694.0 | 723.0 | 755.0 | 804.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|